Clara I. Troccoli

802 total citations
8 papers, 94 citations indexed

About

Clara I. Troccoli is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Clara I. Troccoli has authored 8 papers receiving a total of 94 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Genetics. Recurrent topics in Clara I. Troccoli's work include Prostate Cancer Treatment and Research (3 papers), Estrogen and related hormone effects (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Clara I. Troccoli is often cited by papers focused on Prostate Cancer Treatment and Research (3 papers), Estrogen and related hormone effects (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Clara I. Troccoli collaborates with scholars based in United States. Clara I. Troccoli's co-authors include Priyamvada Rai, Mercè Jordà, Kerry L. Burnstein, Deukwoo Kwon, Yuguang Ban, Karen Kage, Lisa McPherson, Debin Ji, Eric T. Kool and David J. Robbins and has published in prestigious journals such as Nature Communications, Cancer Research and Free Radical Biology and Medicine.

In The Last Decade

Clara I. Troccoli

7 papers receiving 94 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clara I. Troccoli United States 4 76 14 11 10 8 8 94
Charlotte A. Hoogstraten Netherlands 8 89 1.2× 12 0.9× 15 1.4× 13 1.3× 4 0.5× 10 143
Nadine V. Conchinha Portugal 2 51 0.7× 21 1.5× 6 0.5× 6 0.6× 8 1.0× 2 75
Pauline Pfänder Germany 6 54 0.7× 20 1.4× 13 1.2× 6 0.6× 4 0.5× 6 135
Elsie Gonzalez-Hurtado United States 5 69 0.9× 10 0.7× 10 0.9× 5 0.5× 6 0.8× 6 159
Luke V. Loftus United States 3 64 0.8× 19 1.4× 31 2.8× 13 1.3× 7 0.9× 5 108
Zhi‐Zhong Lin China 5 100 1.3× 41 2.9× 15 1.4× 12 1.2× 6 0.8× 5 175
Mikio Takanashi Japan 5 49 0.6× 18 1.3× 17 1.5× 9 0.9× 7 0.9× 5 132
Alexandra Ambrico United States 2 80 1.1× 44 3.1× 13 1.2× 12 1.2× 3 0.4× 2 100
Donghui Sun China 4 83 1.1× 20 1.4× 19 1.7× 10 1.0× 7 0.9× 7 142
Martina Beretta Australia 9 100 1.3× 23 1.6× 15 1.4× 6 0.6× 14 1.8× 20 189

Countries citing papers authored by Clara I. Troccoli

Since Specialization
Citations

This map shows the geographic impact of Clara I. Troccoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara I. Troccoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara I. Troccoli more than expected).

Fields of papers citing papers by Clara I. Troccoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clara I. Troccoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara I. Troccoli. The network helps show where Clara I. Troccoli may publish in the future.

Co-authorship network of co-authors of Clara I. Troccoli

This figure shows the co-authorship network connecting the top 25 collaborators of Clara I. Troccoli. A scholar is included among the top collaborators of Clara I. Troccoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clara I. Troccoli. Clara I. Troccoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Pokharel, Sheela Pangeni, Clara I. Troccoli, Dionysios C. Watson, et al.. (2025). Oncogenic KRAS addiction states differentially influence MTH1 expression and 8-oxodGTPase activity in lung adenocarcinoma. Redox Biology. 82. 103610–103610.
2.
Zhang, Ling, Clara I. Troccoli, Erin A. Jackson, et al.. (2024). Stimulating Soluble Guanylyl Cyclase with the Clinical Agonist Riociguat Restrains the Development and Progression of Castration-Resistant Prostate Cancer. Cancer Research. 85(1). 134–153. 2 indexed citations
3.
Zhang, Ling, Clara I. Troccoli, Michael G. Mohsen, et al.. (2024). Abstract B091: The mammalian 8-oxodGTPase, MTH1, as a novel targetable vulnerability in pancreatic ductal adenocarcinoma. Cancer Research. 84(2_Supplement). B091–B091. 2 indexed citations
4.
Zhang, Ling, Clara I. Troccoli, Julia Zaias, et al.. (2023). Abstract 4790: Oxidation in the nucleotide pool as a novel targetable vulnerability in pancreatic ductal adenocarcinoma. Cancer Research. 83(7_Supplement). 4790–4790. 3 indexed citations
5.
Troccoli, Clara I., Ling Zhang, Debin Ji, et al.. (2019). The Existence of MTH1-independent 8-oxodGTPase Activity in Cancer Cells as a Compensatory Mechanism against On-target Effects of MTH1 Inhibitors. Molecular Cancer Therapeutics. 19(2). 432–446. 12 indexed citations
6.
McPherson, Lisa, Clara I. Troccoli, Debin Ji, et al.. (2019). Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue. DNA repair. 83. 102644–102644. 25 indexed citations
7.
Troccoli, Clara I., Deukwoo Kwon, Yuguang Ban, et al.. (2018). The ROS duality in castration-resistant prostate cancer emergence and progression. Free Radical Biology and Medicine. 128. S75–S75. 1 indexed citations
8.
Troccoli, Clara I., Karen Kage, Deukwoo Kwon, et al.. (2017). Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer. Nature Communications. 8(1). 1204–1204. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026